Enact Holdings, Inc.
US ˙ NasdaqGS ˙ US29249E1091

Introduction

This page provides a comprehensive analysis of the known insider trading history of Matthew M Walsh. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Matthew M Walsh has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:CERT / Certara, Inc. Director 197,559
US:OGN / Organon & Co. Chief Financial Officer 144,484
US:ACT / Enact Holdings, Inc. EVP, Chief Financial Officer 0
US:CTLT / Catalent, Inc. EVP & Chief Financial Officer 103,703
US:LABL / Multi-Color Corp. Director 1,854
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Matthew M Walsh. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases ACT / Enact Holdings, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in ACT / Enact Holdings, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2018-11-16 AGN WALSH MATTHEW M 1,000 157.0000 1,000 157.0000 157,000 364
2018-03-08 AGN WALSH MATTHEW M 1,000 153.9600 1,000 153.9600 153,960
2018-02-21 AGN WALSH MATTHEW M 2,000 160.9400 2,000 160.9400 321,880

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

ACT / Enact Holdings, Inc. Insider Trades
Insider Sales ACT / Enact Holdings, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in ACT / Enact Holdings, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

ACT / Enact Holdings, Inc. Insider Trades
Insider Purchases CERT / Certara, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in ACT / Enact Holdings, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2020-12-15 CERT WALSH MATTHEW M 5,000 23.0000 5,000 23.0000 115,000 324 45.21 111,050 96.57

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

CERT / Certara, Inc. Insider Trades
Insider Sales CERT / Certara, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in ACT / Enact Holdings, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
2022-11-14 CERT WALSH MATTHEW M 12,059 14.7400 12,059 14.7400 177,750 350 12.1200 -31,594 -17.77

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

CERT / Certara, Inc. Insider Trades
Insider Purchases OGN / Organon & Co. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in ACT / Enact Holdings, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2025-05-05 OGN WALSH MATTHEW M 11,400 8.8200 11,400 8.8200 100,548 123 10.3800 17,784 17.69

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

OGN / Organon & Co. Insider Trades
Insider Sales OGN / Organon & Co. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in ACT / Enact Holdings, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

OGN / Organon & Co. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Matthew M Walsh as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2025-05-22 2025-05-21 4 CERT Certara, Inc.
Common Stock
M - Exercise 11,928 197,559 6.43
2025-05-06 2025-05-05 4 OGN Organon & Co.
Common Stock
P - Purchase 11,400 144,484 8.57 8.82 100,548 1,274,349
2025-04-02 2025-03-31 4 OGN Organon & Co.
Common Stock
F - Taxes -3,819 133,084 -2.79 14.51 -55,414 1,931,049
2025-04-02 2025-03-31 4 OGN Organon & Co.
Common Stock
M - Exercise 7,754 136,903 6.00
2025-04-02 2025-03-31 4 OGN Organon & Co.
Common Stock
F - Taxes -5,933 129,149 -4.39 14.51 -86,088 1,873,952
2025-04-02 2025-03-31 4 OGN Organon & Co.
Common Stock
M - Exercise 12,046 135,082 9.79
2025-04-02 2025-03-31 4 OGN Organon & Co.
Common Stock
F - Taxes -7,422 123,036 -5.69 14.51 -107,693 1,785,252
2025-04-02 2025-03-31 4 OGN Organon & Co.
Common Stock
M - Exercise 15,070 130,458 13.06
2025-02-24 2025-02-20 4 OGN Organon & Co.
Common Stock
F - Taxes -1,908 115,388 -1.63 15.29 -29,173 1,764,283
2025-02-24 2025-02-20 4 OGN Organon & Co.
Common Stock
A - Award 5,570 117,296 4.99
2025-02-24 2025-02-20 4 OGN Organon & Co.
Common Stock
F - Taxes -10,662 111,726 -8.71 14.92 -159,077 1,666,952
2025-02-24 2025-02-20 4 OGN Organon & Co.
Common Stock
A - Award 30,414 122,388 33.07
2024-09-05 2024-09-03 4 OGN Organon & Co.
Common Stock
F - Taxes -3,541 91,974 -3.71 20.35 -72,059 1,871,671
2024-09-05 2024-09-03 4 OGN Organon & Co.
Common Stock
A - Award 7,189 95,515 8.14
2024-05-23 2024-05-21 4 CERT Certara, Inc.
Common Stock
M - Exercise 8,663 185,631 4.90
2024-05-07 2024-05-04 4 OGN Organon & Co.
Common Stock
F - Taxes -4,093 88,326 -4.43 19.61 -80,264 1,732,073
2024-05-07 2024-05-04 4 OGN Organon & Co.
Common Stock
M - Exercise 8,310 92,419 9.88
2024-04-03 2024-03-31 4 OGN Organon & Co.
Common Stock
F - Taxes -5,933 84,109 -6.59 18.80 -111,540 1,581,249
2024-04-03 2024-03-31 4 OGN Organon & Co.
Common Stock
M - Exercise 12,046 90,042 15.44
2024-04-03 2024-03-31 4 OGN Organon & Co.
Common Stock
F - Taxes -3,819 77,996 -4.67 18.80 -71,797 1,466,325
2024-04-03 2024-03-31 4 OGN Organon & Co.
Common Stock
M - Exercise 7,753 81,815 10.47
2024-03-01 2024-02-28 4 OGN Organon & Co.
Common Stock
F - Taxes -11,393 74,062 -13.33 18.04 -205,530 1,336,078
2024-03-01 2024-02-28 4 OGN Organon & Co.
Common Stock
M - Exercise 33,044 85,455 63.05
2023-08-08 2023-08-05 4 OGN Organon & Co.
Common Stock
F - Taxes -11,006 52,411 -17.35 21.53 -236,959 1,128,409
2023-08-08 2023-08-05 4 OGN Organon & Co.
Common Stock
M - Exercise 22,347 63,417 54.41
2023-05-19 2023-05-17 4 CERT Certara, Inc.
Common Stock
M - Exercise 9,067 176,968 5.40
2023-05-08 2023-05-04 4 OGN Organon & Co.
Common Stock
F - Taxes -4,043 41,070 -8.96 24.24 -98,002 995,537
2023-05-08 2023-05-04 4 OGN Organon & Co.
Common Stock
M - Exercise 8,310 45,113 22.58
2023-04-04 2023-03-31 4 OGN Organon & Co.
Common Stock
F - Taxes -2,656 36,803 -6.73 23.09 -61,327 849,781
2023-04-04 2023-03-31 4 OGN Organon & Co.
Common Stock
M - Exercise 7,753 39,459 24.45
2022-11-15 2022-11-14 4 CERT Certara, Inc.
Common Stock
S - Sale -12,059 167,901 -6.70 14.74 -177,750 2,474,861
2022-08-09 2022-08-05 4 OGN Organon & Co.
Common Stock
F - Taxes -10,790 31,706 -25.39 32.41 -349,704 1,027,591
2022-08-09 2022-08-05 4 OGN Organon & Co.
Common Stock
M - Exercise 22,343 42,496 110.87
2022-05-18 2022-05-17 4 CERT Certara, Inc.
Restricted Stock Units
A - Award 9,067 9,067
2022-05-05 2022-05-04 4 OGN Organon & Co.
Restricted Stock Units
M - Exercise -8,310 8,310 -50.00
2022-05-05 2022-05-04 4 OGN Organon & Co.
Common Stock
F - Taxes -2,847 20,153 -12.38 32.44 -92,357 653,763
2022-05-05 2022-05-04 4 OGN Organon & Co.
Common Stock
M - Exercise 8,310 23,000 56.57
2022-04-04 2022-03-31 4 OGN Organon & Co.
Stock Option (right to buy)
A - Award 71,649 71,649
2022-04-04 2022-03-31 4 OGN Organon & Co.
Restricted Stock Units
A - Award 23,260 23,260
2021-08-19 2021-08-17 4 OGN Organon & Co.
Stock Option (Right to Buy)
A - Award 44,642 44,642
2021-08-09 2021-08-05 4 OGN Organon & Co.
Restricted Stock Units
M - Exercise 22,343 44,690 99.98
2021-08-09 2021-08-05 4 OGN Organon & Co.
Common Stock
F - Taxes -7,653 14,690 -34.25 28.63 -219,105 420,575
2021-08-09 2021-08-05 4 OGN Organon & Co.
Common Stock
M - Exercise 22,343 22,343 28.63 639,680 639,680
2021-06-04 2021-06-02 4 OGN Organon & Co.
Stock Option (Right to Buy)
A - Award 193,302 193,302
2021-06-04 2021-06-02 4 OGN Organon & Co.
Restricted Stock Units
A - Award 33,044 33,044
2021-06-04 2021-06-02 4 OGN Organon & Co.
Restricted Stock Units
A - Award 24,930 24,930
2021-06-04 2021-06-02 4 OGN Organon & Co.
Restricted Stock Units
A - Award 67,033 67,033
2021-05-18 2021-05-18 4 CERT Certara, Inc.
Common Stock
A - Award 7,059 179,960 4.08
2020-12-16 2020-12-15 4 CERT Certara, Inc.
Common Stock
P - Purchase 5,000 172,901 2.98 23.00 115,000 3,976,723
2020-12-16 2020-12-10 4 CERT Certara, Inc.
Common Stock
A - Award 145,597 167,901 652.78
2020-12-16 2020-12-10 4 CERT Certara, Inc.
Common Stock
J - Other 22,304 22,304
2020-12-11 3 CERT Certara, Inc.
Common Stock
167,901
2020-05-11 2020-05-08 4 AGN Allergan plc
Performance Stock Units
D - Sale to Issuer -28,021 0 -100.00
2020-05-11 2020-05-08 4 AGN Allergan plc
Restricted Stock Units
D - Sale to Issuer -27,618 0 -100.00
2020-05-11 2020-05-08 4 AGN Allergan plc
Ordinary Shares, par value $0.0001
D - Sale to Issuer -12,039 0 -100.00
2020-03-04 2020-03-02 4 AGN Allergan plc
Ordinary Shares, Par value $0.0001
A - Award 15,476 39,657 64.00 193.84 2,999,868 7,687,113
2019-02-21 2019-02-20 4 AGN Allergan plc
Ordinary Shares, Par value $0.0001
F - Taxes -2,235 24,181 -8.46 140.33 -313,638 3,393,320
2018-11-19 2018-11-16 4 AGN Allergan plc
Ordinary Shares, Par value $0.0001
P - Purchase 1,000 26,416 3.93 157.00 157,000 4,147,312
2018-03-08 2018-03-08 4 AGN Allergan plc
Ordinary Shares, par value $0.0001
P - Purchase 1,000 25,416 4.10 153.96 153,960 3,913,047
2018-02-22 2018-02-21 4 AGN Allergan plc
Ordinary Shares, par value $0.0001
P - Purchase 2,000 24,416 8.92 160.94 321,880 3,929,511
2018-02-22 2018-02-20 4 AGN Allergan plc
Performance-Based Restricted Stock Unit
A - Award 28,021 28,021
2018-02-22 2018-02-20 4 AGN Allergan plc
Ordinary Shares, par value $0.0001
A - Award 9,340 22,416 71.43 160.59 1,499,911 3,599,785
2018-02-22 2018-02-20 4 AGN Allergan plc
Ordinary Shares, par value $0.0001
A - Award 13,076 13,076 160.59 2,099,875 2,099,875
2017-08-28 2017-08-24 4 CTLT Catalent, Inc.
Common Stock
F - Taxes -8,245 103,703 -7.37 35.21 -290,306 3,651,383
2017-08-28 2017-08-24 4 CTLT Catalent, Inc.
Common Stock
A - Award 16,191 111,948 16.91
2017-08-01 2017-07-31 4 CTLT Catalent, Inc.
Common Stock
F - Taxes -3,230 95,757 -3.26 34.97 -112,953 3,348,622
2017-07-26 2017-07-24 4 CTLT Catalent, Inc.
Options to purchase Common Stock
A - Award 27,378 27,378
2017-07-26 2017-07-24 4 CTLT Catalent, Inc.
Common Stock
A - Award 5,275 98,987 5.63
2017-06-12 2017-06-09 4 CTLT Catalent, Inc.
Common Stock
S - Sale X -2,759 93,712 -2.86
2017-06-12 2017-06-08 4 CTLT Catalent, Inc.
Common Stock
M - Exercise X -20,374 0 -100.00
2017-06-12 2017-06-08 4 CTLT Catalent, Inc.
Common Stock
M - Exercise X -54,277 0 -100.00
2017-06-12 2017-06-08 4 CTLT Catalent, Inc.
Common Stock
S - Sale X -24,989 96,471 -20.57
2017-06-12 2017-06-08 4 CTLT Catalent, Inc.
Common Stock
F - Taxes -46,903 121,460 -27.86 37.01 -1,735,814 4,495,065
2017-06-12 2017-06-08 4 CTLT Catalent, Inc.
Common Stock
M - Exercise X 20,374 168,363 13.77 14.86 302,758 2,501,874
2017-06-12 2017-06-08 4 CTLT Catalent, Inc.
Common Stock
M - Exercise X 54,277 147,989 57.92 10.71 581,307 1,584,962
2016-10-05 2016-10-03 4 LABL MULTI COLOR Corp
Common Stock
A - Award 994 1,854 115.58
2016-09-13 2016-09-09 4 CTLT Catalent, Inc.
Common Stock
A - Award 20,374 20,374
2016-09-13 2016-09-09 4 CTLT Catalent, Inc.
Common Stock
A - Award 54,277 54,277
2016-07-28 2016-07-26 4 CTLT Catalent, Inc.
Common Stock
A - Award 28,322 28,322
2016-07-28 2016-07-26 4 CTLT Catalent, Inc.
Common Stock
A - Award 5,524 93,712 6.26
2016-06-01 2016-05-27 4 CTLT Catalent, Inc.
Options to purchase Common Stock
M - Exercise 19,124 28,686 200.00
2016-06-01 2016-05-27 4 CTLT Catalent, Inc.
Options to purchase Common Stock
M - Exercise 52,500 0 -100.00
2016-06-01 2016-05-27 4 CTLT Catalent, Inc.
Options to purchase Common Stock
M - Exercise 17,500 0 -100.00
2016-06-01 2016-05-27 4 CTLT Catalent, Inc.
Common Stock
S - Sale -3,524 88,188 -3.84 28.85 -101,667 2,544,224
2016-06-01 2016-05-27 4 CTLT Catalent, Inc.
Common Stock
F - Taxes -15,600 91,712 -14.54 28.85 -450,060 2,645,891
2016-06-01 2016-05-27 4 CTLT Catalent, Inc.
Common Stock
M - Exercise 19,124 107,312 21.69 18.71 357,810 2,007,808
2016-06-01 2016-05-27 4 CTLT Catalent, Inc.
Common Stock
S - Sale -13,255 88,188 -13.07 28.85 -382,407 2,544,224
2016-06-01 2016-05-27 4 CTLT Catalent, Inc.
Common Stock
F - Taxes -39,245 101,443 -27.90 28.85 -1,132,218 2,926,631
2016-06-01 2016-05-27 4 CTLT Catalent, Inc.
Common Stock
M - Exercise 52,500 140,688 59.53 14.86 780,150 2,090,624
2016-06-01 2016-05-27 4 CTLT Catalent, Inc.
Common Stock
S - Sale -4,418 88,188 -4.77 28.85 -127,459 2,544,224
2016-06-01 2016-05-27 4 CTLT Catalent, Inc.
Common Stock
F - Taxes -13,082 92,606 -12.38 28.85 -377,416 2,671,683
2016-06-01 2016-05-27 4 CTLT Catalent, Inc.
Common Stock
M - Exercise 17,500 105,688 19.84 14.86 260,050 1,570,524
2015-10-05 2015-10-01 4 LABL MULTI COLOR Corp
Common Stock
A - Award 860 860
2015-09-04 2015-09-02 4 CTLT Catalent, Inc.
Options to purchase common stock
A - Award 9,562 19,124 100.00
2015-08-31 2015-08-27 4 CTLT Catalent, Inc.
Options to purchase common stock
A - Award 18,123 18,123
2015-08-31 2015-08-27 4 CTLT Catalent, Inc.
Common Stock
A - Award 4,068 88,188 4.84
2015-07-29 2015-07-27 4 CTLT Catalent, Inc.
Options to purchase common stock
M - Exercise X 46,760 0 -100.00
2015-07-29 2015-07-27 4 CTLT Catalent, Inc.
Options to purchase common stock
M - Exercise X 19,267 0 -100.00
2015-07-29 2015-07-27 4 CTLT Catalent, Inc.
Options to purchase common stock
M - Exercise X 18,690 0 -100.00
2015-07-29 2015-07-27 4 CTLT Catalent, Inc.
Common Stock
S - Sale X -15,620 84,120 -15.66 31.18 -487,032 2,622,862
2015-07-29 2015-07-27 4 CTLT Catalent, Inc.
Common Stock
F - Taxes X -31,140 99,740 -23.79 30.50 -949,770 3,042,070
2015-07-29 2015-07-27 4 CTLT Catalent, Inc.
Common Stock
M - Exercise X 46,760 130,880 55.59 10.71 500,800 1,401,725
2015-07-29 2015-07-27 4 CTLT Catalent, Inc.
Common Stock
S - Sale X -6,436 84,120 -7.11 31.18 -200,674 2,622,862
2015-07-29 2015-07-27 4 CTLT Catalent, Inc.
Common Stock
F - Taxes X -12,831 90,556 -12.41 30.50 -391,346 2,761,958
2015-07-29 2015-07-27 4 CTLT Catalent, Inc.
Common Stock
M - Exercise X 19,267 103,387 22.90 10.71 206,350 1,107,275
2015-07-29 2015-07-27 4 CTLT Catalent, Inc.
Common Stock
S - Sale X -5,116 84,120 -5.73 31.18 -159,517 2,622,862
2015-07-29 2015-07-27 4 CTLT Catalent, Inc.
Common Stock
F - Taxes X -13,574 89,236 -13.20 30.50 -414,007 2,721,698
2015-07-29 2015-07-27 4 CTLT Catalent, Inc.
Common Stock
M - Exercise X 18,690 102,810 22.22 14.29 267,080 1,469,155
2015-04-08 2015-04-06 4 CTLT Catalent, Inc.
Options to purchase common stock
M - Exercise -102,043 19,267 -84.12
2015-04-08 2015-04-06 4 CTLT Catalent, Inc.
Common Stock
S - Sale -32,439 84,120 -27.83 30.43 -987,119 2,559,772
2015-04-08 2015-04-06 4 CTLT Catalent, Inc.
Common Stock
F - Taxes -67,987 116,559 -36.84 30.43 -2,068,844 3,546,890
2015-04-08 2015-04-06 4 CTLT Catalent, Inc.
Common Stock
M - Exercise 102,043 184,546 123.68 10.71 1,092,881 1,976,488
2015-04-08 2015-04-06 4 CTLT Catalent, Inc.
Common Stock
S - Sale -2,000 82,503 -2.37 30.43 -60,860 2,510,566
2015-03-31 2015-03-27 4 CTLT Catalent, Inc.
Common Stock
F - Taxes -11,039 84,503 -11.55 30.10 -332,274 2,543,540
2015-02-18 2015-02-13 4 CTLT Catalent, Inc.
Common Stock
S - Sale -3,200 95,542 -3.24 28.11 -89,952 2,685,686
2014-07-31 3 CTLT Catalent, Inc.
Common Stock
197,484
2014-07-31 3 CTLT Catalent, Inc.
Common Stock
197,484
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)